Lobbying Information
Subject Matters
- Economic Development
- Health
- Industry
- Intellectual Property
- International Trade
- Research and Development
- Science and Technology
- Taxation and Finance
Subject Matter Details
Legislative Proposal, Bill or Resolution
- Food and Drug Act - An Act respecting food, drugs, cosmetics and therapeutic devices. Discussions relating to progressive licensing and the modernization of the Food & Drug Act.
- Patent Act - An Act respecting patents of invention with regard to Intellectual Property Protection for pharmaceutical products - federal court decisions that have changed the disclosure requirements regarding the utility of an invention.
Policies or Program
- Free trade treaty agreement as it relates to the North American Free Trade Agreement (NAFTA) and free trade negotiations as it relates to Columbia, India, and the European Union.
- Patented Medicines Prices Review Board (PMPRB) proposed regulations, in regards to pharmaceutical pricing policy.
- The government's Science and Technology Strategy potential policies & programs pertaining to the biopharmaceutical industry.
Regulation
- Intellectual Property - Changes to Patented Medicine (Notice of Compliance) (PMNOC) regulations - important regulations that can affect Eli Lilly's business.
- Patented Medicine Notice of Compliance (PMNOC) Regulations - enforcement of Intellectual Property with respect to the Canadian pharmaceutical industry.
Communication Techniques
-
Written communication
-
Oral communication
The lobbyist has arranged or expects to arrange one or more meetings on behalf of the client between a public office holder and any other person in the course of this undertaking.
Government Institutions
-
Agriculture and Agri-Food Canada (AAFC)
-
Federal Economic Development Agency for Southern Ontario (FedDev)
-
Finance Canada (FIN)
-
Global Affairs Canada (GAC)
-
Health Canada (HC)
-
House of Commons
-
Indigenous Services Canada (ISC)
-
Innovation, Science and Economic Development Canada (ISED)
-
Patented Medicine Prices Review Board (PMPRB)
-
Prime Minister's Office (PMO)
-
Privy Council Office (PCO)
-
Public Safety Canada (PS)
-
Senate of Canada
Client Details
Government funding
No government funding was received during the last completed financial year.
Client Contact Information
Address:
3650 Danforth Avenue
Toronto, ON M1N 2E8
Canada
Telephone number:
416-699-7222
Client representative
Lauren Fischer, Vice President, Corporate Affairs
Parent Company Information
- Eli Lilly & Company
-
Lilly Corporate Center
Indianapolis, IN 46225
United States of America
Coalition Members Information
Eli Lilly Canada Inc. is not a coalition.
Individual, organization or corporation with a Direct Interest Beneficiary Information
The activities of Eli Lilly Canada Inc. are not controlled or directed by another individual, organization or corporation with a direct interest in the outcome of this undertaking.
Subsidiary Beneficiary Information
- BIOTECCANADA (Partner)
-
420-130 Albert Street
Ottawa, ON K1P 5G4
Canada
- Innovative Medicines Canada (Partner)
-
55 Metcalfe Street
Ottawa, ON K1P 6L5
Canada
Lobbyist Details
Beth Palmer
|
Public offices held
Business address:
46 Elgin St.
#400
Ottawa, ON K2P 5K6
Canada
Telephone number:
613-563-4455
Consultant Firm and Address
Firm:
Earnscliffe Strategies
Address:
46 Elgin St.
#400
Ottawa, ON K2P 5K6
Canada
Telephone number:
613-563-4455